Preoperative Bevacizumab in Combination With Paclitaxel and Carboplatin in Surgically Resectable Non-Small Cell Lung Cancer

被引：3
|
作者：
Bertino, Erin [1 ]
Villalona-Calero, Miguel A. [1 ]
Ross, Patrick [2 ]
Grever, Michael [3 ]
Otterson, Gregory A. [3 ]
机构：
[1] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
来源：
ANNALS OF THORACIC SURGERY | 2011年 / 91卷 / 02期
关键词：
TRIAL; SURGERY; CHEMOTHERAPY;
D O I：
10.1016/j.athoracsur.2010.07.047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：640 / 640
页数：1
相关论文
共 50 条
  • [1] Immunotherapy in surgically resectable non-small cell lung cancer
    Owen, Dwight
    Chaft, Jamie E.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S404 - S411
  • [2] PROGNOSIS OF PATIENTS WITH NON-SMALL CELL LUNG CANCER RECEIVED CARBOPLATIN, PACLITAXEL AND BEVACIZUMAB (CPB).
    Kazuyori, Taisuke
    Fujimoto, Shota
    Yamanaka, Yumie
    Shinohara, Wakako
    Komatsu, Akina
    Ichikawa, Akihiro
    Kojima, Akira
    Kuwano, Kazuyoshi
    RESPIROLOGY, 2015, 20 : 88 - 88
  • [3] Meloxicam in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer
    Takahashi, T
    Ueda, S
    Kogure, Y
    Ebisawa, M
    Asai, G
    Yamamoto, N
    LUNG CANCER, 2005, 49 : S271 - S271
  • [4] Paclitaxel and carboplatin in nonoperable non-small cell lung cancer
    Kosmidis, P
    Mylonakis, N
    Fountzilas, G
    Samantas, E
    Athanasiadis, A
    Skarlos, D
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 16 - 18
  • [5] The Combination Chemotheray of Gemcitabine, Carboplatin and Bevacizumab in Patients with Advanced Non-Small Cell Lung Cancer
    Lee, Moon-Hyung
    Whang, Jin Ah
    Ahn, Young Mee
    Noh, Yong Ho
    Nam, Seung Hyun
    Kim, Bong-Seog
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S402 - S402
  • [6] THE COMBINATION CHEMOTHERAPY OF GEMCITABINE, CARBOPLATIN AND BEVACIZUMAB IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Kim, Bong Seog
    Ahn, Young Mi
    Lee, Moon Hyung
    Suh, Kang Heum
    Nam, Seung-Hyun
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1158 - S1158
  • [7] Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer
    Boutsikou, Eftimia
    Kontakiotis, Theodoros
    Zarogoulidis, Paul
    Darwiche, Kaid
    Eleptheriadou, Ellada
    Porpodis, Konstantinos
    Galaktidou, Grammati
    Sakkas, Leonidas
    Hohenforst-Schmidt, Wolfgang
    Tsakiridis, Kosmas
    Karaiskos, Theodoros
    Zarogoulidis, Konstantinos
    ONCOTARGETS AND THERAPY, 2013, 6 : 125 - 134
  • [8] Carboplatin and Paclitaxel With vs Without Bevacizumab in Older Patients With Advanced Non-Small Cell Lung Cancer
    Zhu, Junya
    Sharma, Dhruv B.
    Gray, Stacy W.
    Chen, Aileen B.
    Weeks, Jane C.
    Schrag, Deborah
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (15): : 1593 - 1601
  • [9] THE EFFECT OF CARBOPLATIN PACLITAXEL AND BEVACIZUMAB FOR ADVANCED NON-SMALL CELL LUNG CANCER WITH MALIGNANT PLEURAL EFFUSION
    Kazuyori, Taisuke
    Tamura, Nobumasa
    Sasaki, Ryoko
    Hirano, Yuuta
    Tone, Kazuya
    Shinohara, Wakako
    Kojima, Akira
    Kuwano, Kazuyoshi
    RESPIROLOGY, 2017, 22 : 116 - 116
  • [10] Safety and Efficacy of Combining Sunitinib with Bevacizumab plus Paclitaxel/Carboplatin in Non-small Cell Lung Cancer
    Socinski, Mark A.
    Scappaticci, Frank A.
    Samant, Meghna
    Kolb, Margaret M.
    Kozloff, Mark F.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (03) : 354 - 360
12345